Hao Zhou

Statistics

Publications

Citations

144

H-Index

Active since

2021

Affiliations

University of Electronic Science and Technology of China(Current)

Wuhan University

Zhongnan Hospital of Wuhan University

Hao Zhou is an author at University of Electronic Science and Technology of China specializing in tumor-associated inflammation, pharmacology, and oncology.

ORCID

Publications per year

2021–2025

Publications

Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway

Xiao Li, Xue Li, Peilin Cao et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 107 citations · Full text

Medicine, Cancer Biology, Oncology +17

Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis

Dan Li, Fei Fan, Hua Yu et al. · Frontiers in Pharmacology · 2021 · 14 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Lactate/Cysteine Dual-Consuming Probiotic–Nanomedicine Biohybrid System for Enhanced Cancer Chemo-Immunotherapy

Tian‐Qiu Xie, Xiao Yan, You‐Teng Qin et al. · Nano Letters · 2024 · 13 citations

Pharmacy, Immunology, Oncology +17

Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy

Yan-Tong Lin, Ran Meng, Shi‐Man Zhang et al. · Nano Letters · 2025 · 10 citations

Medicine, Oncology, Pharmacology +17

1–4 of 4